Market Place
Sourcing Support
All News #Library
Biotech
Dewpoint Therapeutics Unveils Oral MYC Modulator Data At AACR
21 Apr 2026 //
FIRSTWORD PHARMA
Dewpoint Selects First-in-Class MYC Modulator Lead Candidate
11 Feb 2026 //
GLOBENEWSWIRE
Dewpoint Doses First Patient in DPTX3186 Trial of Advance Tumors
04 Feb 2026 //
GLOBENEWSWIRE
Dewpoint Therapeutics Unveils ALS Treatment Candidate For TDP-43
08 Jan 2026 //
GLOBENEWSWIRE
Dewpoint Pharma Initiates Viral Condensate Phenomics Atlas
06 Jan 2026 //
GLOBENEWSWIRE
Dewpoint Therapeutics Opens IND For WNT-Driven Cancer Condensate
21 Oct 2025 //
GLOBENEWSWIRE
Dewpoint Therapeutics Presents At AACR-NCI-EORTC 2025
14 Oct 2025 //
GLOBENEWSWIRE
Dewpoint Secure Series D Fund for Gastric Cancer Drug Development
10 Sep 2025 //
GLOBENEWSWIRE
Dewpoint Announces DPTX3496 For Colorectal, Breast, Lung Cancer
29 Jan 2025 //
GLOBENEWSWIRE
Dewpoint & ConcertAI Announce Translational Oncology Partnership
12 Dec 2024 //
GLOBENEWSWIRE
Dewpoint & Mitsubishi Tanabe Collaborate on ALS Treatment
04 Dec 2024 //
GLOBENEWSWIRE
Dewpoint collects new pharma partner for preclinical ALS program
04 Dec 2024 //
FIERCE BIOTECH
Dewpoint Nominates DPTX3186 for Wnt-Driven Cancer Treatment
28 Oct 2024 //
#N/A
Bayer and Dewpoint sign Licensing Agreement for Heart Disease Program
25 Oct 2024 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.